3-methyl-4-oxo-4-phenylbutanoic acid | 7315-67-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-methyl-4-oxo-4-phenylbutanoic acid
• 英文别名: 3-Benzoylbuttersaeure；β-methyl-γ-oxo-γ-phenylbutanoic acid
• CAS: 7315-67-5
• 化学式: C₁₁H₁₂O₃
• mdl: MFCD16068284
• 分子量: 192.214
• InChiKey: YBDWBJYRJYONCB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.272
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-methyl-4-oxo-4-phenylbutanoic acid 在 肼 作用下， 生成 盐酸格拉司琼杂质7
  参考文献：
  名称：

  非甾体孕酮受体配体。2.对骨细胞孕激素受体具有选择性的高亲和力配体。

  摘要：

  发现了一系列新的非甾体杂环化合物，它们显示与TE85骨肉瘤细胞的孕激素受体的细胞类型选择性，高亲和力（纳摩尔）结合，但与T47D和ZR75人乳腺癌细胞的孕激素受体的结合亲和力> 1 microM。建立了一组化合物的结构活性关系，并选择了具有代表性的类似物1-（3,4-二氯苯甲酰基）-3-苯基-1,4,5,6-四氢哒嗪++ +（1i，RWJ 25333）进一步评估。RWJ 25333刺激人成骨细胞样细胞的体外增殖，但不刺激人乳腺细胞的体外增殖。

  DOI：

  10.1021/jm00025a004
• 作为产物：
  描述：

  柠康酸酐 在 三氯化铝 、 溶剂黄146 、 锌 作用下， 生成 3-methyl-4-oxo-4-phenylbutanoic acid
  参考文献：
  名称：

  The cis- and trans-β-Aroyl-α- and β-methylacrylic Acids and β-Aroyl-α-methylenepropionic Acids

  摘要：

  DOI：

  10.1021/ja01116a045

文献信息

• Nonsteroidal Progesterone Receptor Ligands. 2. High-Affinity Ligands with Selectivity for Bone Cell Progesterone Receptors
  作者：Donald W. Combs、Kimberly Reese、Lyndon A. M. Cornelius、Joseph W. Gunnet、Ellen V. Cryan、Kay S. Granger、Jerold J. Jordan、Keith T. Demarest

  DOI：10.1021/jm00025a004

  日期：1995.12

  A novel series of nonsteroidal heterocycles was discovered which display cell-type selective, high-affinity (nanomolar) binding to the progesterone receptors from TE85 osteosarcoma cells but > 1 microM binding affinity to the progesterone receptors from T47D and ZR75 human breast carcinoma cells. Structure-activity relationships were developed for a set of these compounds, and a representative analog

  发现了一系列新的非甾体杂环化合物，它们显示与TE85骨肉瘤细胞的孕激素受体的细胞类型选择性，高亲和力（纳摩尔）结合，但与T47D和ZR75人乳腺癌细胞的孕激素受体的结合亲和力> 1 microM。建立了一组化合物的结构活性关系，并选择了具有代表性的类似物1-（3,4-二氯苯甲酰基）-3-苯基-1,4,5,6-四氢哒嗪++ +（1i，RWJ 25333）进一步评估。RWJ 25333刺激人成骨细胞样细胞的体外增殖，但不刺激人乳腺细胞的体外增殖。
• THERAPEUTIC AGENT FOR DIABETES
  申请人：Japan Tobacco Inc.

  公开号：EP0885869A1

  公开（公告）日：1998-12-23

  A therapeutic agent for diabetes, which comprises a compound of the formula [I] wherein Xis a group of the formula wherein R4 and R5 are the same or different and each is a hydrogen atom, an optionally substituted alkyl having 1 to 5 carbon atoms and the like, and R6 is a hydrogen atom or an amino-protecting group; R1 is an optionally substituted alkyl having 1 to 5 carbon atoms, an optionally substituted alkenyl having 2 to 6 carbon atoms and the like, R2 is a hydrogen atom, an optionally substituted alkyl having 1 to 5 carbon atoms and the like, R2' is a hydrogen atom, and R3 is an optionally substituted alkyl having 1 to 5 carbon atoms and the like, a prodrug thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof and a solvate thereof. The compound of the present invention shows superior blood sugar decreasing action on the state of hyperglycemia, but does not affect the blood sugar when it is in the normal range or in the hypoglycemic state, which means that it is free of serious side effects such as hypoglycemia. Therefore, the compound of the present invention is useful as a therapeutic drug for diabetes and also useful as a preventive of the chronic complications of diabetes.

  用于治疗糖尿病的疗法剂，包括公式[I]的化合物 其中 X是公式的组 其中R4和R5相同或不同，每个都是氢原子，可选地取代的具有1至5个碳原子的烷基等等，R6是氢原子或氨基保护基团；R1是具有1至5个碳原子的可选取代烷基，具有2至6个碳原子的可选取代烯基等等，R2是氢原子，具有1至5个碳原子的可选取代烷基等等，R2'是氢原子，R3是具有1至5个碳原子的可选取代烷基等等，其前药，药用可接受盐，水合物和溶剂化物。 本发明的化合物在血糖升高状态下表现出优越的降血糖作用，但在正常范围或低血糖状态下不影响血糖，这意味着它没有低血糖等严重副作用。因此，本发明的化合物作为治疗糖尿病的药物很有用，也用作预防糖尿病慢性并发症。
• Azo anions in systhesis. pt 1. t-butylhydrazones as acyl-anion equivalents
  作者：Jack E. Baldwin、Robert M. Adlington、Jeffrey C. Bottaro、Jayant N. Kolhe、Matthew W.D. Perry、Ashok U. Jain

  DOI：10.1016/s0040-4020(01)87647-x

  日期：1986.1

  tautomerisation and hydrolysis gave α-hydroxy ketones, ketones, and γ-keto esters in good yield, thereby providing a convenient new acyl-anion equivalent. Reaction of these lithium salts with aldehydes and ketones, followed by elimination provided a new route to azo alkenes.

  醛-丁基hydr的锂盐与亲电子试剂（醛，酮，卤代烷，巴豆酸酯）反应生成陷获的-丁基偶氮化合物；互变异构化和水解以良好的产率得到α-羟基酮，酮和γ-酮酯，从而提供了方便的新的酰基-阴离子当量。这些锂盐与醛和酮的反应，然后消除，提供了一条通往偶氮烯烃的新途径。
• [EN] THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS<br/>[FR] DÉRIVÉS DE LA THIÉNO [2, 3-B] PYRIDINE EN TANT QU'INHIBITEURS DE RÉPLICATION VIRALE
  申请人：UNIV LEUVEN KATH

  公开号：WO2010130842A1

  公开（公告）日：2010-11-18

  The present invention relates to a series of compounds of formula (A) having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, as well as to novel intermediates useful in one or more steps of such syntheses. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. This invention further relates to the use of such compounds as medicines or in the manufacture of a medicament useful for the treatment of animals suffering from viral infections, in particular HIV infection. This invention further relates to methods for the treatment of viral infections in animals by the administration of a therapeutical amount of such compounds, optionally combined with one or more other drugs having anti-viral activity.

  本发明涉及一系列具有抗病毒活性的化合物(A)的公式，更具体地说是具有抑制HIV（人类免疫缺陷病毒）复制的特性。该发明还涉及制备这类化合物的方法，以及在这类合成的一个或多个步骤中有用的新中间体。该发明还涉及包含有效量这类化合物作为活性成分的药物组合物。本发明进一步涉及将这类化合物用作药物或用于制造用于治疗患有病毒感染的动物，尤其是HIV感染的药物。本发明还涉及通过给予这类化合物的治疗量，可选地与一个或多个具有抗病毒活性的其他药物结合，来治疗动物的病毒感染的方法。
• Michael additions of hydrazones for carbon–carbon bond formation
  作者：Jack E. Baldwin、Robert M. Adlington、Jeffrey C. Bottaro、Ashok U. Jain、Jayant N. Kolhe、Matthew W. D. Perry、Ian M. Newington

  DOI：10.1039/c39840001095

  日期：——

  The lithium salts of t-butyl-and trityl-hydrazones react with methyl crotonate to form C-trapped azo-esters and similar products were observed from a thermal ene-reaction of aldehyde t-butylhydrazones with methyl acrylate or acrylonitrile, and aldehyde phenylhydrazones with methyl acrylate; these products can be diverted into synthetically useful γ-keto-esters, γ-keto-nitriles, saturated esters, γ

  叔丁基hydr和三苯甲基-的锂盐与巴豆酸甲酯反应形成C捕获的偶氮酯，并且通过醛叔丁基hydr与丙烯酸甲酯或丙烯腈的热烯反应，以及醛苯hydr与丙烯的热烯反应观察到类似的产物。丙烯酸甲酯 这些产品可以分为合成有用的γ-酮酯，γ-酮腈，饱和酯，γ-烷基-2-吡咯烷酮和γ-氨基酯。